Naruhiro Ishida

1.1k total citations
23 papers, 752 citations indexed

About

Naruhiro Ishida is a scholar working on Ophthalmology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Naruhiro Ishida has authored 23 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Ophthalmology, 9 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Naruhiro Ishida's work include Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (5 papers) and Ocular Surface and Contact Lens (5 papers). Naruhiro Ishida is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (5 papers) and Ocular Surface and Contact Lens (5 papers). Naruhiro Ishida collaborates with scholars based in Japan, United Kingdom and France. Naruhiro Ishida's co-authors include Shiro Mita, Shinichiro Hirai, Akira Ichihara, Tomohiro Tamura, Katsuhiko Nakata, Atsushi Shimazaki, Hideaki Hara, Reiko Ishida, Takashi Kojima and Eiki Goto and has published in prestigious journals such as Journal of Molecular Biology, Molecular and Cellular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Naruhiro Ishida

23 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naruhiro Ishida Japan 13 358 264 248 135 103 23 752
Takazumi Taniguchi Japan 15 257 0.7× 405 1.5× 99 0.4× 131 1.0× 44 0.4× 25 660
Arivalagan Muthusamy United States 14 258 0.7× 235 0.9× 127 0.5× 94 0.7× 28 0.3× 35 715
Ryõ Andõ Japan 13 211 0.6× 176 0.7× 38 0.2× 126 0.9× 25 0.2× 73 591
Deshea L Harris United States 21 322 0.9× 402 1.5× 410 1.7× 862 6.4× 65 0.6× 58 1.3k
Rossella Titone United States 16 333 0.9× 53 0.2× 165 0.7× 148 1.1× 28 0.3× 23 754
Darren J. Lee United States 16 223 0.6× 263 1.0× 92 0.4× 91 0.7× 18 0.2× 28 701
Tsunehiko Yoshida United States 8 373 1.0× 351 1.3× 34 0.1× 165 1.2× 39 0.4× 11 675
Ai Ling Wang United States 12 603 1.7× 565 2.1× 42 0.2× 172 1.3× 62 0.6× 17 978
Judith Lechner United Kingdom 12 398 1.1× 644 2.4× 116 0.5× 503 3.7× 31 0.3× 18 1.1k

Countries citing papers authored by Naruhiro Ishida

Since Specialization
Citations

This map shows the geographic impact of Naruhiro Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naruhiro Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naruhiro Ishida more than expected).

Fields of papers citing papers by Naruhiro Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naruhiro Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naruhiro Ishida. The network helps show where Naruhiro Ishida may publish in the future.

Co-authorship network of co-authors of Naruhiro Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Naruhiro Ishida. A scholar is included among the top collaborators of Naruhiro Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naruhiro Ishida. Naruhiro Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miki, Atsuya, et al.. (2022). Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan. Advances in Therapy. 39(5). 2085–2095. 8 indexed citations
2.
Takazawa, Kenji, et al.. (2021). Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Clinical ophthalmology. Volume 15. 3997–4003. 6 indexed citations
3.
Nagata, Atsushi, Tomomi Higashide, Atsushi Shimazaki, et al.. (2014). OCT Evaluation of Neuroprotective Effects of Tafluprost on Retinal Injury After Intravitreal Injection of Endothelin-1 in the Rat Eye. Investigative Ophthalmology & Visual Science. 55(2). 1040–1040. 14 indexed citations
4.
5.
Odani‐Kawabata, Noriko, et al.. (2010). Effects of Repeated Administrations of Tafluprost, Latanoprost, and Travoprost on Optic Nerve Head Blood Flow in Conscious Normal Rabbits. Journal of Ocular Pharmacology and Therapeutics. 26(2). 181–186. 31 indexed citations
6.
Sasaoka, Masaaki, Takazumi Taniguchi, Masamitsu Shimazawa, et al.. (2006). Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Experimental Eye Research. 83(3). 629–637. 39 indexed citations
7.
Ishida, Naruhiro, Noriko Odani‐Kawabata, Atsushi Shimazaki, & Hideaki Hara. (2006). Prostanoids in the Therapy of Glaucoma. Cardiovascular Drug Reviews. 24(1). 1–10. 38 indexed citations
8.
Ishida, Naruhiro, et al.. (2005). Continuous Monitoring of Circadian Variations in Intraocular Pressure by Telemetry System Throughout a 12-Week Treatment with Timolol Maleate in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 21(6). 436–444. 21 indexed citations
9.
Takagi, Yasutaka, et al.. (2004). Effects of Bunazosin Hydrochloride on Ciliary Muscle Constriction and Matrix Metalloproteinase Activities. Journal of Glaucoma. 13(4). 312–318. 6 indexed citations
10.
Ohashi, Yoshiki, Reiko Ishida, Takashi Kojima, et al.. (2003). Abnormal protein profiles in tears with dry eye syndrome. American Journal of Ophthalmology. 136(2). 291–299. 178 indexed citations
11.
Ishida, Naruhiro, Shinichiro Hirai, & Shiro Mita. (1997). Immunolocalization of Aquaporin Homologs in Mouse Lacrimal Glands. Biochemical and Biophysical Research Communications. 238(3). 891–895. 104 indexed citations
12.
Ishida, Naruhiro, et al.. (1996). Expression and Characterization of Lacrimal Gland Water Channels inXenopusOocytes. Biochemical and Biophysical Research Communications. 224(1). 1–4. 7 indexed citations
13.
Tamura, Tomohiro, Fumio Osaka, Tomihiko Higuti, et al.. (1994). Isolation and Characterization of α-Type HC3 and β-Type HC5 Subunit Genes of Human Proteasomes. Journal of Molecular Biology. 244(1). 117–124. 18 indexed citations
14.
Ishida, Naruhiro, Keiji Tanaka, Tomohiro Tamura, et al.. (1993). Mos is degraded by the 26S proteasome in a ubiquitin‐dependent fashion. FEBS Letters. 324(3). 345–348. 51 indexed citations
15.
Tamura, Tomohiro, Naoki Shimbara, Masashi Aki, et al.. (1992). Molecular Cloning of cDNAs for Rat Proteasomes: Deduced Primary Structures of Four Other Subunits1. The Journal of Biochemistry. 112(4). 530–534. 29 indexed citations
16.
17.
Miyawaki, Nobuaki, et al.. (1991). Antihypertensive Effect of a Novel Calcium Antagonist, SD-3211, in Experimental Hypertensive Rats. Journal of Cardiovascular Pharmacology. 18(6). 855–862. 16 indexed citations
18.
Ishida, Naruhiro, et al.. (1991). The protective effects of SA3443, a novel cyclic disulfide, on chronic liver injuries in rats. Journal of Hepatology. 13(2). 200–207. 9 indexed citations
19.
Ishida, Naruhiro, et al.. (1990). Effect of SA3443, a novel cyclic disulfide compound, on chronic liver injury induced by carbon tetrachloride in rats. The Japanese Journal of Pharmacology. 52. 239–239. 1 indexed citations
20.
Nishimura, Kazuo, Katsuhiko Nakata, Nobuaki Miyawaki, et al.. (1989). The cardiohemodynamic effect of a novel Ca++ antagonist, SD-3211, in the dog. The Japanese Journal of Pharmacology. 49. 212–212. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takazumi Taniguchi Breakdown of academic impact, for papers by Arivalagan Muthusamy Breakdown of academic impact, for papers by Ryõ Andõ Breakdown of academic impact, for papers by Deshea L Harris Breakdown of academic impact, for papers by Rossella Titone Breakdown of academic impact, for papers by Darren J. Lee Breakdown of academic impact, for papers by Tsunehiko Yoshida Breakdown of academic impact, for papers by Ai Ling Wang Breakdown of academic impact, for papers by Judith Lechner
Rankless by CCL
2026